Annual long term liabilities:
$471.00M+$124.39M(+35.89%)Summary
- As of today (July 1, 2025), APLS annual total long term liabilities is $471.00 million, with the most recent change of +$124.39 million (+35.89%) on December 31, 2024.
- During the last 3 years, APLS annual long term liabilities has fallen by -$80.25 million (-14.56%).
- APLS annual long term liabilities is now -24.96% below its all-time high of $627.68 million, reached on December 31, 2020.
Performance
APLS Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$464.69M-$6.31M(-1.34%)Summary
- As of today (July 1, 2025), APLS quarterly total long term liabilities is $464.69 million, with the most recent change of -$6.31 million (-1.34%) on March 31, 2025.
- Over the past year, APLS quarterly long term liabilities has increased by +$114.73 million (+32.78%).
- APLS quarterly long term liabilities is now -32.02% below its all-time high of $683.62 million, reached on June 30, 2021.
Performance
APLS quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
APLS Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.9% | +32.8% |
| 3 y3 years | -14.6% | -16.9% |
| 5 y5 years | +62.8% | +22.5% |
APLS Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.6% | +35.9% | -14.2% | +34.1% |
| 5 y | 5-year | -25.0% | +62.8% | -32.0% | +34.1% |
| alltime | all time | -25.0% | >+9999.0% | -32.0% | >+9999.0% |
APLS Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $464.69M(-1.3%) |
| Dec 2024 | $471.00M(+35.9%) | $471.00M(-0.5%) |
| Sep 2024 | - | $473.49M(+0.5%) |
| Jun 2024 | - | $470.99M(+34.6%) |
| Mar 2024 | - | $349.96M(+1.0%) |
| Dec 2023 | $346.62M(-18.0%) | $346.62M(-13.4%) |
| Sep 2023 | - | $400.31M(+1.3%) |
| Jun 2023 | - | $395.34M(-7.7%) |
| Mar 2023 | - | $428.10M(+1.3%) |
| Dec 2022 | $422.74M(-23.3%) | $422.74M(-6.1%) |
| Sep 2022 | - | $450.03M(-16.9%) |
| Jun 2022 | - | $541.29M(-3.1%) |
| Mar 2022 | - | $558.85M(+1.4%) |
| Dec 2021 | $551.26M(-12.2%) | $551.26M(+12.8%) |
| Sep 2021 | - | $488.78M(-28.5%) |
| Jun 2021 | - | $683.62M(+1.3%) |
| Mar 2021 | - | $674.80M(+7.5%) |
| Dec 2020 | $627.68M | $627.68M(+6.9%) |
| Sep 2020 | - | $587.22M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $580.05M(+53.0%) |
| Mar 2020 | - | $379.20M(+31.1%) |
| Dec 2019 | $289.26M(+1032.8%) | $289.26M(+2.5%) |
| Sep 2019 | - | $282.22M(+131.3%) |
| Jun 2019 | - | $122.03M(+66.7%) |
| Mar 2019 | - | $73.21M(+186.7%) |
| Dec 2018 | $25.54M(-4.1%) | $25.54M(-6.0%) |
| Sep 2018 | - | $27.16M(+0.5%) |
| Jun 2018 | - | $27.01M(+0.5%) |
| Mar 2018 | - | $26.87M(+0.9%) |
| Dec 2017 | $26.63M(>+9900.0%) | $26.63M(>+9900.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $26.57M(>+9900.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00 |
| Dec 2013 | $0.00 | - |
FAQ
- What is Apellis Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual long term liabilities year-on-year change?
- What is Apellis Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Apellis Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of APLS is $471.00M
What is the all time high annual long term liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total long term liabilities is $627.68M
What is Apellis Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, APLS annual total long term liabilities has changed by +$124.39M (+35.89%)
What is Apellis Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of APLS is $464.69M
What is the all time high quarterly long term liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total long term liabilities is $683.62M
What is Apellis Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, APLS quarterly total long term liabilities has changed by +$114.73M (+32.78%)